The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Flu Vaccine market was valued at US$ 5505 million in 2023 and is anticipated to reach US$ 7673.2 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
Report Scope
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
Segment by Type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
Segment by Application
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Flu Vaccine Market Overview
1.1 Product Overview and Scope of Flu Vaccine
1.2 Flu Vaccine Segment by Type
1.2.1 Global Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Segment by Application
1.3.1 Global Flu Vaccine Market Value by Application: (2024-2030)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Flu Vaccine Revenue 2019-2030
1.4.2 Global Flu Vaccine Sales 2019-2030
1.4.3 Global Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Flu Vaccine Market Competition by Manufacturers
2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flu Vaccine, Product Type & Application
2.7 Flu Vaccine Market Competitive Situation and Trends
2.7.1 Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flu Vaccine Players Market Share by Revenue
2.7.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Flu Vaccine Global Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global Flu Vaccine Sales by Region: 2025-2030
3.3 Global Flu Vaccine Global Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global Flu Vaccine Revenue by Region: 2025-2030
3.4 North America Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America Flu Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Flu Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Flu Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Flu Vaccine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hulan Bio Flu Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Flu Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CCBIO Flu Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu Vaccine Industry Chain Analysis
7.2 Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu Vaccine Production Mode & Process
7.4 Flu Vaccine Sales and Marketing
7.4.1 Flu Vaccine Sales Channels
7.4.2 Flu Vaccine Distributors
7.5 Flu Vaccine Customers
8 Flu Vaccine Market Dynamics
8.1 Flu Vaccine Industry Trends
8.2 Flu Vaccine Market Drivers
8.3 Flu Vaccine Market Challenges
8.4 Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
